AA
NAVB

Ancora Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Ancora Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed – – 2605
2025
Q4 		$0 Hold
100
– – ﹤0.01% 2551
2025
Q3 		$0 Hold
100
– – ﹤0.01% 2111
2025
Q2 		$0 Hold
100
– – ﹤0.01% 2096
2025
Q1 		$0 Buy
+100
New – ﹤0.01% 1939

Ancora Advisors's NAVB Position: Q1 2026 in Review

Ancora Advisors sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2026, closing a stake of 100 shares.

Ancora Advisors first reported a position in NAVB in Q1 2025 and held it in 4 quarters. The position peaked at $0 in Q4 2025. 0 funds tracked by Wall St. Rank hold NAVB as of Q1 2026.

  • Ancora Advisors reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2026 after selling out during the quarter.
  • Ancora Advisors sold 100 Navidea Biopharmaceuticals Inc. shares in Q1 2026.
  • Ancora Advisors first reported a position in Navidea Biopharmaceuticals Inc. in Q1 2025 and held it in 4 quarters.
  • Ancora Advisors's Navidea Biopharmaceuticals Inc. position peaked at $0 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.